Evaluation of β-cell replication in mice transgenic for hepatocyte growth factor and placental lactogen: Comprehensive characterization of the G1/S regulatory proteins reveals unique involvement of p21 cip

Diabetes

Volumn 55, Issue 1, 2006, Pages 70-77

  Cozar Castellano, Irene ^a   Weinstock, Matthew ^a   Haught, Marcia ^a   Velázquez Garcia, Silvia ^a   Sipula, Darinka ^a   Stewart, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; EARLY GROWTH RESPONSE FACTOR 1; MYC PROTEIN; PLACENTA LACTOGEN; PROTEIN MDM2; PROTEIN P107; PROTEIN P130; PROTEIN P15; PROTEIN P16; PROTEIN P18; PROTEIN P19; PROTEIN P21; PROTEIN P27; PROTEIN P53; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; SCATTER FACTOR; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIVISION; CELL NUCLEUS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HOMOZYGOSITY; MALE; MITOGENESIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION;

EID: 33644773614     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.01.06.db05-0632     Document Type: Article

References (42)

1. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
2. Herold KC, Hagopian W, Auger JA, Poumain-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698, 2002
3. Garcia-Ocaña A, Takane K, Syed MA, Philbrick WM, Vasavada RC, Stewart AF: Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass and induces mild hypoglycemia, J Biol Chem 275:1226-1232, 2000
4. Vasavada RC, Garcia-Ocaña A, Zawalich WS, Sorenson RL, Dann PS, Ogren L, Talamantes F, Stewart AF: Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J Biol Chem 275:15399-15406, 2000
5. 1. Diabetes 53:149-159, 2004
6. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46, 2004
7. Swenne I: Glucose-stimulated DNA replication in the pancreatic islets during the development of the rat fetus. Diabetes 34:803-807, 1985
8. Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44:249-256, 1995
9. Ptasznik A, Beattie GM, Mally MI, Cirulli V, Lopez A, Hayek A: Phosphatidylinositol 3-kinase is a negative regulator of cellular differentiation. J Cell Biol 137:1127-1136, 1997
10. Sorenson RL, Brelje TC: Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307, 1997
11. Harvey M, Vogel H, Lee EY-P, Bradley A, Donehower LA: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151, 1995
12. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T: Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484, 1994
13. Hanahan D: Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122, 1985
14. Chung DC, Brown SB, Grahme-Cooke F, Seto M, Warshaw AL, Jensen RT, Arnold A: Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab 85:4373-4378, 2000
15. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC: Overexpression of cyclin D1 in pancreatic β-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54:712-719, 2005
16. Georgia S, Bhushan A: β-Cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114:963-968, 2004
17. Kushner J, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF: Cyclins D2 and D1 are essential for postnatal pancreatic beta cell growth. Mol Cell Biol 25:3752-3762, 2005
18. Fajas L, Annicotte J-S, Miard S, Sarruf D, Watanabe M, Auwerx J: Impaired pancreatic growth, β cell mass and β cell function in E2F1-/- mice. J Clin Invest 113:1288-1295, 2004
19. Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, Moreno B, Lloreta J, Field SJ, Real FX, Zubiaga AM: Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double mutant mice. J Clin Invest 113:1398-1407, 2004
20. Rane S, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of expression of cdk4 causes insulin-deficient diabetes and cdk4 activation results in beta cell hyperplasia. Nat Genet 22:44-52, 1999
21. Tsutsui T, Hesabi B, Moons D, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H: Targeted disruption of cdk4 delays cell cycle entry with enhanced p27-kip activity. Mol Cell Biol 19:7011-7019, 1999
22. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534, 1999
23. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG: Cyclin D1: normal and abnormal functions. Endocrinology 145:5439-5447, 2004
24. Pagano M, Jackson PK: Wagging the dogma: tissue-specific cell cycle control in the mouse embryo. Cell 118:535-538, 2004
25. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M: Deletion of cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182, 2005
26. Vasavada R, Cavaliere C, D'Ercole AJ, Dann P, Burtis WJ, Madlener AL, Zawalich K, Zawalich W, Philbrick WM, Stewart AF: Overexpression of PTHrP in the pancreatic islets of transgenic mice causes hypoglycemia, hyperinsulinemia and islet hyperplasia. J Biol Chem 271:1200-1208, 1996
27. Garcia-Ocaña A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera J-C, Stewart AF: Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes. Diabetes 50:2752-2762, 2001
28. Fujinaka Y, Sipula D, Garcia-Ocaña A, Vasavada RC: Characterization of mice doubly transgenic for parathyroid hormone-related protein and murine placental lactogen. Diabetes 53:3120-3130, 2004
29. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ: Radiation induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557, 1995
30. Martin J, Hunt SL, Dubus P, Sotillo R, Nehme-Pelluard F, Magnuson MA, Parlow AF, Malumbres M, Ortega S, Barbacid M: Genetic rescue of cdk-4-null mice restores pancreatic beta cell proliferation but not homeostatic cell number. Oncogene 22:5261-5269, 2003
31. waf1/cip1-deficient mice. Cancer Res 61:6234-6238, 2001
32. Stout LE, Svensson AM, Sorenson RL: Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 138:1592-1603, 1997
33. Garcia-Ocaña A, Vasavada RC, Cebrian A, Reddy V, Takane K, Lopez-Talavera J-C, Stewart AFS: Double transgenic overexpression of PTHrP and HGF in the pancreatic islet: effects on β-cell growth and function. Diabetes 50 (Suppl. 2):A525, 2001
34. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen SQ, Williams B, Theodorou E, Jacks T: Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization. Genes Dev 14:3037-3050, 2000
35. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA: The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14:1789-1797, 1997
36. Kaneto H, Kajimoto Y, Fujitani Y, Matsuoka T, Sakamoto K, Matsuhisa M, Yamasaki Y, Hori M: Oxidative stress induces p21 expression in pancreatic isla cells: possible implication in beta cell dysfunction. Diabetologia 42:1093-1097, 1999
37. waf1/cip1. FEBS Lett 455:315-320, 1999
38. Maitra A, Hansel DE, Afgani P, Ashfaq R, Rahman A, Naji A, Deng S, Geradts J, Hawthorne LA, House MG, Yeo CJ: ZGlobal expression analysis of well differentiatred pancreatic endocrtine neoplasms using oligonucleotide microarrays. Clin Cancer Res 9:5988-5995, 2003
39. Bunz F, Dutriaux A, Lengauer C, Walkman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501, 1998
40. cip/waf undergo normal development but are defective in G1 checkpoint control. Cell 82:675-684, 1995
41. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512, 1999
42. kip cdk 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583, 1999